The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...
If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.
"We can use initially our own financial resources, but then [in the] second phase we can use [a] third party's money," ...
Titan Biotech Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 644.53 Crore) operating in Chemicals sector. Titan Biotech Ltd. key Products/Revenue Segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback